Increased I-FABP levels have been demonstrated in intestinal ischemia (63, 64), celiac disease (65), necrotizing enterocolitis (66), etc
Adults received either placebo or EMP+ (Vit A 5760IU, Vit C 600 mg, Vit D 1440 IU, Vit E 360 IU, B1 18 mg, B2 13.5 mg, B3 90 mg,B5 21.6 mg, B6 36 mg, B9 1440 g, B12 900 g, Biotin 1080 g, Pantothenic acid21.6 mg, Ca 1320 mg, Fe 13.74 mg, P 840mg, I 204 g, Mg 600 mg, Zn 48 mg, Se204 g, Cu 7.2 mg, Mn 9.6 mg, Cr 624 g, Mo 144 g, K 240 mg, Germaniumsesquioxide 20.7 mg, B 2400 g, V 1194 g, Ni 29.4 g, Choline bitartrate 540mg, DL-phenylalanine 360 mg, Citrus bioflavonoids 240 mg, Inositol 180 mg,Glutamine 180 mg, L-methionine 60 mg, Gingko biloba 36 mg, grape seed extract45 mg)
The weight loss in the SELECT trial ( 9.39%) was 35% less than weight loss delivered in semaglutides STEP 1 trial (14.9%)
Berberine activates AMPK to lower glucose and support weight loss with fewer side effects